Hostname: page-component-586b7cd67f-dlnhk Total loading time: 0 Render date: 2024-11-25T00:29:41.946Z Has data issue: false hasContentIssue false
  • English
  • Français

Persistence of Fluoroquinolone-Resistant, Multidrug-Resistant Streptococcus pneumoniae in a Long-Term–Care Facility Efforts to Reduce Intrafacility Transmission

Published online by Cambridge University Press:  21 June 2016

Alicia M. Fry ,
Chi Chi N. Udeagu ,
Montse Soriano-Gabarro ,
Scott Fridkin ,
Diana Musinski ,
Leslie LaClaire ,
John Elliott ,
Debra J. P. Cook ,
John Kornblum  and
Marcelle Layton
...Show all authors
Alicia M. Fry
Affiliation:
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia
Chi Chi N. Udeagu
Affiliation:
Bureau of Communicable Diseases, New York City Department of Health, New York City, New York
Montse Soriano-Gabarro
Affiliation:
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia
Scott Fridkin
Affiliation:
Division of Health Care Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Diana Musinski
Affiliation:
Northeast Counties Infection Control Practitioner Network, Brooklyn, New York
Leslie LaClaire
Affiliation:
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
John Elliott
Affiliation:
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Debra J. P. Cook
Affiliation:
Public Health Laboratories, New York City Department of Health, New York City, New York
John Kornblum
Affiliation:
Public Health Laboratories, New York City Department of Health, New York City, New York
Marcelle Layton
Affiliation:
Bureau of Communicable Diseases, New York City Department of Health, New York City, New York
Cynthia G. Whitney*
Affiliation:
Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
*
Centers for Disease Control and Prevention, Mailstop C-23, 1600 Clifton Road NE, Atlanta, GA 30333[email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

We describe an effort to reduce transmission of a multidrug-resistant Streptococcus pneumoniae (MDRSP) in a long-term-care facility (LTCF).

Design:

Longitudinal cross-sectional study.

Setting:

An LTCF in New York City with ongoing disease due to an MDRSP strain among residents with AIDS since a 1995 outbreak. The MDRSP outbreak strain was susceptible to vancomycin but not to other antimicrobials tested, including fluoroquinolones.

Participants:

Residents and staff members of the LTCF during 1999 through 2001.

Intervention:

Implementing standard infection control measures, and developing and implementing "enhanced standard" infection control measures, modified respiratory droplet prevention measures to reduce inter-resident transmission.

Results:

Before the intervention, nasopharyngeal carriage of the MDRSP outbreak strain was detected in residents with AIDS and residents with tracheostomies who were not dependent on mechanical ventilation. The prevalence of nasopharyngeal carriage of the MDRSP outbreak strain was 7.8% among residents who had AIDS and 14.6% among residents with tracheostomies. After training sessions on standard and enhanced standard infection control measures, the staff appeared to have good knowledge and practice of the infection control measures. After the intervention, new transmission among residents with tracheostomies was prevented; however, these residents were prone to persistent tracheal carriage and needed ongoing enhanced standard infection control measures. Ongoing transmission among residents with AIDS, a socially active group, was documented, although fewer cases of disease due to the outbreak strain occurred.

Conclusions:

Infection control contributed to less transmission of MDRSP in the LTCF. Additional strategies are needed to reduce transmission and carriage among certain resident populations.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 26 , Issue 3 , March 2005 , pp. 239 - 247
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Strausbaugh, IJ, Crossley, KB, Nurse, BA, et al.Antimicrobial resistance in long-term-care facilities. Infect Control Hosp Epidemiol 1996;17:129–140.Google Scholar
2.Gleich, S, Morad, Y, Echague, R, et al.Streptococcus pneumoniae serotype 4 outbreak in a home for the aged: report and review of recent outbreaks. Infect Control Hosp Epidemiol 2000;21:711–717.Google Scholar
3.Whitney, CG, Farley, MN, Hadler, J, et al.Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000;346:1917–1924.Google Scholar
4.Feikin, DR, Schuchat, A, Kolczak, M, et al.Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health 2000;90:223–229.Google Scholar
5.Butler, JC, Breiman, RF, Campbell, JF, et al.Polysaccharide pneumococcal vaccine efficacy: an evaluation of current recommendations. JAMA 1993;270:1826–1831.Google Scholar
6.Shapiro, ED, Berg, AT, Austrian, R, et al.The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325: 1453–1460.Google Scholar
7.Koivula, I, Stén, M, Leinonen, M, Mäkelä, PH. Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med 1997;103:281–290.Google Scholar
8.Simberkoff, MS, Cross, AP, Al-Ibrahim, M, et al.Efficacy of pneumococcal vaccine in high-risk patients: results of a Veterans Administration Cooperative Study. N Engl J Med 1986;315:1318–1327.CrossRefGoogle ScholarPubMed
9.Örtqvist, Å, Hedlund, J, Burman, LA, et al.Randomized trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-age and elderly people. Lancet 1998;351:399–403.Google Scholar
10.Nichol, KL, Baken, L, Wuorenma, J, Nelson, A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999;159:2437–2442.Google Scholar
11.Nuorti, JP, Butler, JC, Crutcher, JM, et al.An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvacci-nated nursing home residents. N Engl J Med 1998;338:1861–1868.Google Scholar
12.Carter, RJ, Sorenson, G, Heffernan, R, et al.Failure to control an outbreak of multidrug-resistant Streptococcus pneumoniae in a long-term-care facility: emergence and ongoing transmission of a fluoro-quinolone-resistant strain. Infect Control Hosp Epidemiol 2005;26:248–255.Google Scholar
13.O'Brien, KL, Dagan, R, Yagupsky, P, et al.Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol 2001;39:1021–1024.Google Scholar
14.National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA: National Committee for Clinical Laboratory Standards; 1999.Google Scholar
15.Elliott, JA, Farmer, KD, Facklam, RR. Sudden increase in isolation of Group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type. J Clin Microbiol 1998;36:2115–2116.CrossRefGoogle Scholar
16.Garner, JS. Guideline for isolation precautions in hospitals: the Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17:53–79.Google Scholar
17.Breiman, RF, Keller, DW, Phelan, MA, et al.Evaluation of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Arch Intern Med 2000;160:2633–2638.Google Scholar
18.Dworkin, MS, Ward, JW, Hanson, DL, Jones, JL, Kaplan, JE. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis 2001;32:794–800.Google Scholar
19.French, N, Nakiyingi, J, Carpenter, LM, et al.23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000;355:2106–2111.Google Scholar
20.Fedson, DS. Pneumococcal conjugate vaccination for adults: why it's important for children. Pediatr Infect Dis J 2000;19:183–186.Google Scholar
21.Loeffler, JM, Nelson, D, Fischetti, VA. Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 2001; 294:2170–2172.Google Scholar
22.Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance: Infect Control Hosp Epidemiol 1995;16:105–113.Google Scholar